Introduction
Leukotrienes are oxidation products of arachidonic acid synthesized via the 5-lipoxygenase pathway (Piacentini & Kaliner, 1991) . These eicosanoids not only have potent inflammatory effects in man and experimental animals but also affect bronchial and vascular smooth muscle tone (Bray, 1986; Batt, 1992) . Elevated levels of leukotrienes or their metabolites have been detected in tissue or fluids of different pathological conditions (Bray, 1986; Busse & Gaddy, 1991; Salmon & Garland, 1991) . For example, the urinary excretion of leukotriene E4 (LTE4, a metabolite of LTD4) and bronchoalveolar lavage fluid levels of LTC4 was enhanced after allergen challenge in allergic human subjects (Taylor et al., 1989; Wenzel et al., 1990) . These levels of leukotrienes appeared to correlate with the severity of the bronchoconstrictor response (Wenzel et al., 1990; Salmon & Garland, 1991) . 20-OH-LTB4, a metabolite of LTB4, has been found in sputum of patients with asthma (Lam et al., 1988) and synovial fluid from patients with rheumatoid arthritis (Davidson et al., 1983) . In addition, biologically active levels of LTB4-like material were found in antigen-treated skin of allergic subjects (Barr et al., 1984) . Because of the widespread presence of leukotrienes in pathological conditions and their potent biological effects, great efforts have been made to identify drugs which can inhibit leukotriene synthesis (5-Author for correspondence. lipoxygenase inhibitors) or drugs which may interfere with their action (LTD4 and LTB4 antagonists) (McMillan & Walker, 1992) . It is hoped that these drugs will be a major improvement in the treatment of chronic inflammatory human diseases.
In asthma and other related diseases, it has been suggested that eosinophils and eosinophil products play an important role in the lesion of the airways and development of bronchial hyperresponsiveness (Djukanovic et al., 1990) . Leukotrienes, specially LTB4, have been shown to be potent eosinophil chemoattractants both in vivo (Faccioli et al., 1991) and in vitro (Czarnetzki & Mertensmeier, 1985; Sehmi et al., 1991) . Interestingly, human eosinophils also release LTC4 which may contribute to bronchoconstriction in airway disease (Kauffman et al., 1987) .
In the guinea-pig, the intradermal injection of different chemotactic agents leads to accumulation of eosinophils in skin sites (Faccioli et al., 1991; Collins et al., 1993; Teixeira et al., 1993a) . In this model, LTB4 is potent in inducing the accumulation of "'1In-eosinophils but causes very little increase in microvascular permeability and subsequent oedema formation (Faccioli et al., 1991) . The injection of antigen in sites previously sensitized with an IgG1-rich sera also leads to accumulation of "'In-eosinophils and to oedema formation in a passive cutaneous anaphylaxis (PCA) reaction (Weg et al., 1992; Teixeira et al., 1993a,b) . Oedema formation in a and to newly synthesized LTD4 and PAF (Weg et al., 1991) . However, the mediators responsible for the accumulation of "'In-eosinophils in the same reaction do not seem to depend on PAF (as assessed by use of the PAF antagonist WEB 2086) or leukotrienes (as assessed by use of the weak leukotriene synthesis inhibitor PF 5901) (Weg et al., 1992) . While the endogenous mediators responsible for inducing "'Ineosinophil accumulation in the PCA reaction are unknown, it has recently been established that the mechanism of their accumulation involves the leukocyte cell adhesion molecules CD18 and VLA-4 Teixeira et al., 1994a) . In view of the potent action of exogenous LTB4 in inducing "'In-eosinophil accumulation in the guinea-pig, we have reevaluated, by using the potent 5-lipoxygenase inhibitor ZM 230487 (formerly ICI 230487), the role of this mediator in contributing to the accumulation of "'In-eosinophils in a PCA reaction in guinea-pig skin.
Methods
Preparation of zymosan-activated plasma Zymosan-activated plasma (ZAP) was used as a source of guinea-pig CSa des-Arg. ZAP was prepared by incubating heparinized (1O iu ml-') plasma obtained from naive guineapigs (Harlan Porcellus, Oxon, 350-400 g) with zymosan (5 mg ml-') for 30 min at 370C. Zymosan was then removed by centrifugation (2 x 10 min at 3000 g). The activated plasma was desalted with a PD-10 Sephadex G-25M column and stored in aliquots at -20°C.
Preparation ofpassive cutaneous anaphylaxis sera and reactions Details of the preparation of IgGl-rich sera are described elsewhere (Weg et al., 1991 (Figure 3a) but did not significantly reduce oedema formation induced by AA (Figure 3b) .
Results

Effect
The mechanisms of AA-induced local oedema formation were examined in further experiments. We tested the effects of a PAF antagonist (WEB 2086) and an anti-histamine (mepyramine) used alone or in combination with ZM 230487 against AA-induced oedema formation. Administration of ZM 230487 or mepyramine (2.5 x 10-8 mol per site) partially inhibited AA-induced oedema formation while WEB 2086 (10-7 mol per site) was without effect (Figure 4 ). These doses of WEB 2086 and mepyramine effectively inhibited oedema formation induced by PAF (10-9 mol per site) and histamine (2.5 x 108 mol per site), respectively (data not shown). However, the combination of ZM 230487, WEB 2086 and mepyramine effectively suppressed AA-induced oedema formation by 76% (Figure 4 ) while the combination of any two of the antagonists/inhibitor did not show similar inhibitory effects (data not shown).
Effect of ZM 230487 on other inflammatory mediators ZM 230487 was tested against "'In-eosinophil accumulation and oedema formation induced by PAF (10-pmol per site), LTB4 (5 x 10-' mol per site) and ZAP (30% in saline).
PAF-induced "1In-eosinophil accumulation was slightly but significantly inhibited by ZM 230487 while LTB4-induced "'In-eosinophil accumulation was significantly enhanced by the compound (Figure 5a ). ZM 230487 had no effect on ZAP-induced responses ( Figure 5 ). In the same experiments, AA-induced "'In-eosinophil accumulation was abrogated and oedema formation partially suppressed by ZM 230487 Effect of ZM 230487 on local inflammation in a passive cutaneous anaphylaxis reaction
The injection of antigen (BGG) in sites previously sensitized with a IgGl-rich anti-serum (anti-BGG) leads to a dosedependent "'In-eosinophil accumulation and oedema formation in a PCA reaction (Weg et al., 1992; Teixeira et al., 1993a) (Figure 6 ). ZM 230487, when co-injected with 0.1 sg and 1.0gig of antigen per site, significantly inhibited the accumulation of "'In-eosinophils by 72% and 44%, respectively (Figure 6a ). Oedema formation measured in the same sites was not affected (Figure 6b ). Again in these experiments, ZM 230487 abrogated AA-induced "'In-eosinophil accumulation (Figure 6a ) but had little effect on AA-induced oedema formation (Figure 6b) . Weg et al. (1992) have shown that WEB 2086, when tested alone, had no effect on oedema formation or "'In-eosinophil accumulation in a PCA reaction. In the present study, we also examined the effect of WEB 2086. As shown in Figure 7 , -------------WEB 2086 abrogated PAF-induced "I1n-eosinophil accumulation but had no effect on the PCA reaction when tested alone or when tested in combination with ZM 230487.
Discussion
The increased prevalence of asthma and other inflammatory diseases even with the anti-inflammatory therapy available at present warrants a search for more effective treatment (Piacentini & Kaliner, 1991; Salmon & Garland, 1991) . The potent biological effects of leukotrienes together with their widespread presence in different pathological conditions make these mediators of considerable interest. The protective effects of LTD4 antagonists against allergen-induced bronchoconstriction in man (O'Shaughnessy et al., 1993) and in exercise-induced asthma (Makker et al., 1993) further support the importance of leukotrienes in the pathogenesis of asthma (Cheng, 1992) . It is hoped that the development of drugs that inhibit 5-lipoxygenase and thus reduce the synthesis not only of peptidoleukotrienes (LTD4, LTC4) but also of LTB4 will add substantially to the protective effects of LTD4 antagonists since 5-lipoxygenase inhibitors may also have anti-inflammatory effects. Special interest has been given to a series of non-redox inhibitors of 5-lipoxygenase because of their efficacy both in vitro and in vivo and the stereospecificity observed with methoxyalkyl thiazole analogues (McMillan et al., 1991; McMillan & Walker, 1992) . A related series, methoxy tetrahydropyrans, includes ZD2138 (formerly ICI D2138; McMillan et al., 1992) which is undergoing clinical evaluation and a close achiral analogue, ZM 230487 (Crawley et al., 1993) , which was employed in these studies.
In rabbit skin, intradermal injection of high doses of AA (>10-8 mol per site) causes an inflammatory response (oedema formation and neutrophil accumulation) which is dependent on the formation of LTB4 and PGE2 (Aked & Foster, 1987) and can be modulated pharmacologically with 5-lipoxygenase inhibitors (Aked et al., 1986; McMillan et al., 1992) . In the guinea-pig skin, i.d. injection of AA caused a dose-dependent accumulation of "'In-eosinophils. In contrast to the rabbit skin (Aked et al., 1986) , oedema formation was only of mild intensity and only significant at the top dose of AA tested (3 x 10-8 mol per site). Ibuprofen partially inhibited oedema formation suggesting that vasodilator prostaglandins may be important in this reaction (Williams & Peck, 1977) . The effects of ZM 230487 were more complicated since they partially inhibited oedema formation at higher doses (>100 I mol per site) but potentiated at lower doses. Indeed the interaction between leukotrienes in guinea-pig skin is complicated since they can have vasoconstrictor effects in addition to permeability-increasing effects in the cutaneous microcirculation (Hellewell & Williams, 1988) . In this species, LTD4 causes potent increase in microvascular permeability (Ueno et al., 1981) whereas LTC4 is a more potent vasoconstrictor (Hellewell & Williams, 1988) . It is possible that at lower doses, ZM 230487 is interfering with the action of any LTC4 (vasoconstrictor) generated. Vasoconstrictors or drugs which inhibit vasodilatation are known to inhibit inflammation in rabbit and guinea-pig skin (Brain et al., 1989; Teixeira et al., 1993b) . It was surprising that AA-induced oedema formation was not abolished by ZM 230487 since in the same skin sites "'In-eosinophil accumulation was completely blocked. We found that AA-induced oedema formation could be effectively inhibited when a combination of a PAF antagonist, an anti-histamine and ZM 230487 was used (Figure 4) . This observation is identical to that found in earlier studies in our laboratory in which a combination of similar mediator antagonists was also necessary to abrogate oedema formation in a PCA reaction in guinea-pig skin (Weg et al., 1991) .
Accumulation of "'In-eosinophils was abrogated by ZM 230487 suggesting that endogenous leukotrienes are important for AA-induced "'In-eosinophil accumulation. Some workers have described chemoattractant properties for peptidoleukotrienes (in particular LTD4) in guinea-pig conjunctiva (Spada et al., 1986) and lung (Crean et al., 1989) but studies in our department (Weg, unpublished observations) could not detect any "'In-eosinophil accumulation in response to i.d. injection of doses of LTD4 similar to or higher than those of LTB4 in guinea-pig skin. In contrast, LTB4 is a potent agonist for "'In-eosinophil accumulation in the model (Faccioli et al., 1991) . Thus, it is probable that LTB4 is the main leukotriene responsible for "'In-eosinophil accumulation in guinea-pig skin induced by AA but further experiments using a specific LTB4 antagonist are necessary to confirm this idea. We have used the LTB4 antagonist LY 255,883 but it did not produce consistent inhibition of LTB4-induced "'In-eosinophil accumulation in guinea-pig skin (data not shown). The possible cellular sources of leukotrienes in our system have not been investigated but they could be the mast cell or even migrating neutrophils. Guinea-pig eosinophils also release LTB4 as their main leukotriene product (Hirata et al., 1990) .
Ibuprofen, a cyclo-oxygenase inhibitor, partially inhibited "'In-eosinophil accumulation induced by AA. This inhibition was not reversed by PGEI suggesting that suppression of vasodilator prostaglandins was not the mechanism by which ibuprofen inhibited AA-induced "'In-eosinophil accumulair r.
tion (data not shown). However, the demonstration that PGE1 alone may inhibit "'In-eosinophil accumulation induced by different stimuli when injected in guinea-pig skin (Teixeira et al., 1993a) complicates interpretation of these experiments. Nevertheless other vasodilators (CGRP and SNP) that do not share the inhibitory effect of PGE1 on 1In-eosinophil accumulation (Teixeira et al., 1993a) were unable to reverse the effects of ibuprofen on AA-induced 1In-eosinophil accumulation, despite all three vasodilators greatly potentiating AA-induced oedema formation even in the presence of ibuprofen (data not shown). It is possible that ibuprofen is partially inhibiting 5-lipoxygenase (5-LO) in guinea-pig skin. For example it has an IC50 of 69.5 LM on LTB4 generation by rat leukocytes (Bray, 1986) . Alternatively, it may be having some non-specific inhibitory effects on leukocyte function, as previously described (Nielson & Webster, 1987) , which inhibits their accumulation. Another interesting possibility is that ibuprofen may be inhibiting local production of prostaglandin D2 (PGD2). Indeed, PGD2
is able to elicit accumulation of eosinophils in dog trachea (Emery et al., 1989) . However, in guinea-pig skin, we have no evidence for the release of PGD2 after i.d. injection of AA and this mediator (PGD2) only weakly induced the accumulation of "'1In-eosinophils (data not shown).
PAF is a potent eosinophil chemoattractant and activator (Wardlaw et al., 1986; Kroegel et al., 1991) . Nevertheless, guinea-pig eosinophils seem to be less responsive to PAF than to LTB4 (Coeffier et al., 1991; Faccioli et al., 1991 ) (See Figure 5) . Interestingly, PAF-induced "'In-eosinophil accumulation was partially inhibited by ZM 230487. Indeed, PAF is capable of releasing leukotrienes in different experimental conditions and this may account for some of its effects (Voelkel et al., 1982; Anderson & Fennessy, 1988; Kidney et al., 1993) . Another interesting finding was the small but consistent enhancement of LTB4-induced "'Ineosinophil accumulation by ZM 230487. We have not addressed this finding in greater detail but it is possible that ZM 230487 is inhibiting the action of vasoconstrictor leukotrienes (LTC4 potently vasoconstricts in guinea-pig skin; Hellewell & Williams, 1988) . If this is true, locally produced LTC4 may be modulating the inflammatory effects of cutaneously-injected LTB4.
The migration of inflammatory cells into lungs of sensitized subjects challenged with antigen may be important in the development of late phase response (Pradalier, 1993) . Even though the microcirculation of the skin and bronchial tree may be different, the study of the mechanisms involved in this migration and its pharmacological modulation may give insights into pathological events in the lung. In a PCA reaction in guinea-pig skin, ZM 230487 significantly inhibited "'In-eosinophil accumulation but had no effect on oedema formation. This suggests an important role for leukotrienes as agonists of 'In-eosinophil accumulation in this reaction.
The addition of a potent PAF antagonist had no further inhibitory effect on the accumulation of "'In-eosinophils.
Future studies will be aimed at characterizing the other mediator(s) generated in the PCA reaction that may lead to '1In-eosinophil accumulation, including the possibility of mast cell-derived cytokines.
Our group has previously shown that the 5-LO inhibitor, PF 5901, was ineffective on inflammation induced in a guinea-pig PCA reaction (Weg et al., 1992) . The lesser potency of PF 5901 compared with ZM 230487 may explain these findings, suggesting that almost complete inhibition of 5-LO is necessary to be able to measure an inhibitory effect in the PCA reaction. A similar conclusion has been drawn from clinical studies with 5-LO inhibitors and LTD4 antagonists in man (see Hui & Barnes, 1993 for review). Efficacy in acute bronchospasm was only apparent when inhibition of leukotriene synthesis or action was complete. Alternatively, extensive metabolism of PF 5901 in vivo and its high capacity for binding to proteins may prevent it from reaching its site of action in sufficient concentration in guinea-pig skin (Musser & Kreft, 1992) .
Thus it seems that a product of 5-LO, probably LTB4, is important for the accumulation of "'In-eosinophils in a PCA reaction in guinea-pig. This, taken together with the results of others (Richards et al., 1991; Sehmi et al., 1991; Hidi et al., 1992; Ishida et al., 1993) , support a major role for LTB4 in the guinea-pig and makes this animal (and this PCA model) suitable for studying the effects of inhibitors of leukotriene synthesis or action in vivo.
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